Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04639219
Title A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations (DPT01)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca

Advanced Solid Tumor


Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.